Oncolytics Biotech (Canada)
Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Oncolytics Biotech (Canada), Canada, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
47%
Total
Publications
245
Total Open
Publications
115
Total
Citations
7.2K
Open Access
Percentage
47%
Total
Publications
245
Total Open
Publications
115
Total
Citations
7.2K
Breakdown
Publisher Open
18%
Both
22%
Other Platform Open
6%
Closed
54%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 45%
43
Hybrid 27%
26
No Guarantees 28%
27
Other Platform Open
Domain 89%
59
Other Internet 12%
8
Institution 8%
5
Preprint 2%
1
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 59 |
DOI | Other Internet | 7 |
Europe PMC | Domain | 2 |
Unknown Repository | Other Internet | 1 |
University of Melbourne - Minerva Access | Institution | 1 |
universiteitleiden.nl OAI-PMH Repository | Institution | 1 |
The University of Arizona - UA Campus Repository | Institution | 1 |
Research Square | Preprint | 1 |
Jackson Laboratory - The Mouseion at the JAXlibrary | Institution | 1 |
DANS - Data Archiving and Networked Services | Institution | 1 |